SVS.H Stock Financial Analysis - Solarvest BioEnergy Inc. (TSXV) Stock

Overview

Solarvest BioEnergy Inc., headquartered in Canada, operates within the biotechnology industry, focusing on the development and utilization of algal-based production systems to express pharmaceutical proteins and other high-value products. A standout project of theirs includes using their patented algae technology, which encompasses enhanced growth and harvesting methodologies, to produce organic and sustainable omega-3 fatty acids. This endeavor not only targets the health supplements market but also explores applications in pharmaceuticals and nutraceuticals, thereby addressing a growing demand for organic and plant-based nutritional products. Solarvest’s innovative approach leverages genetic engineering and fermentation processes, positioning itself as a pioneer in sustainable bio-solutions with broad market implications.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The operating income for Solarvest BioEnergy Inc. as of April 30, 2025 is -0.50 MM.
The net income for Solarvest BioEnergy Inc. as of April 30, 2025 is -0.55 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-04-30		-0.50	-0.55
2025-01-31		-0.74	-0.83
2024-10-31		-0.64	-0.74
2024-07-31		-0.71	-0.80
2024-04-30	0.00	-1.22	-1.32
2024-01-31	0.00	-1.65	-1.72
2023-10-31	0.00	-2.01	-2.26
2023-07-31	0.00	-2.18	-2.41
2023-04-30	-0.10	-1.81	-2.02
2023-01-31	0.00	-1.55	-1.75
2022-10-31	0.00	-1.51	-1.62
2022-07-31	0.00	-1.52	-1.63
2022-04-30	0.11	-2.33	-2.51
2022-01-31	0.01	-2.56	-2.73
2021-10-31	0.01	-2.46	-2.28
2021-07-31	0.01	-2.33	-3.46
2021-04-30	0.01	-1.57	-2.23
2021-01-31	0.01	-1.26	-2.29
2020-10-31	0.01	-1.33	-2.71
2020-07-31

Income Statement: EPS

The earnings per share basic for Solarvest BioEnergy Inc. as of April 30, 2025 is -0.01.
The earnings per share diluted for Solarvest BioEnergy Inc. as of April 30, 2025 is -0.01.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-04-30	-0.01	-0.01
2025-01-31	-0.01	-0.01
2024-10-31	-0.01	-0.01
2024-07-31	-0.01
2024-04-30	-0.02	-0.02
2024-01-31	-0.03	-0.03
2023-10-31	-0.04	-0.04
2023-07-31	-0.04
2023-04-30	-0.04	-0.04
2023-01-31	-0.03	-0.03
2022-10-31	-0.03	-0.03
2022-07-31	-0.03
2022-04-30	-0.05	-0.05
2022-01-31	-0.05	-0.05
2021-10-31	-0.04	-0.04
2021-07-31	-0.07	-0.07
2021-04-30	-0.04	-0.05
2021-01-31	-0.05	-0.06
2020-10-31	-0.06	-0.07
2020-07-31	-0.04	-0.04

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Solarvest BioEnergy Inc. as of April 30, 2025 is -0.68 MM.
The cash from investing activities for Solarvest BioEnergy Inc. as of April 30, 2025 is 1.20 MM.
The cash from financing activities for Solarvest BioEnergy Inc. as of April 30, 2025 is -0.46 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-04-30	-0.68	1.20	-0.46
2025-01-31	-0.90	1.20	-0.30
2024-10-31	-0.59	0.16	0.43
2024-07-31	-0.67	0.16	0.51
2024-04-30	-0.75	0.17	0.63
2024-01-31	-0.64	0.18	0.51
2023-10-31	-1.06	-0.28	1.34
2023-07-31	-1.13	-0.29	1.42
2023-04-30	-1.09	-0.30	1.26
2023-01-31	-1.11	-0.32	1.32
2022-10-31	-1.22	-0.02	0.41
2022-07-31	-1.52	-0.03	0.18
2022-04-30	-2.28	-0.05	0.21
2022-01-31	-2.86	-0.05	2.66
2021-10-31	-2.58	0.63	2.67
2021-07-31	-2.46	0.64	2.66
2021-04-30	-1.96	1.37	2.83
2021-01-31	-1.11	1.43	0.10
2020-10-31	-1.02	0.77	0.12
2020-07-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-04-30
2025-01-31
2024-10-31
2024-07-31
2024-04-30
2024-01-31
2023-10-31
2023-07-31
2023-04-30
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-04-30
2025-01-31
2024-10-31
2024-07-31
2024-04-30
2024-01-31
2023-10-31
2023-07-31
2023-04-30
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31

Management Effectiveness

The roa for Solarvest BioEnergy Inc. as of April 30, 2025 is -1.10.
The roic for Solarvest BioEnergy Inc. as of April 30, 2025 is -1.34.
The croic for Solarvest BioEnergy Inc. as of April 30, 2025 is -0.01.
The ocroic for Solarvest BioEnergy Inc. as of April 30, 2025 is -1.07.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-04-30	-1.10		-1.34	-0.01	-1.07
2025-01-31	-1.10		-1.34	-0.01	-1.07
2024-10-31	0.00
2024-07-31	-2.71
2024-04-30	-1.53
2024-01-31	-1.79
2023-10-31	-1.98
2023-07-31	-2.03
2023-04-30	-1.23		-1.90	-0.12	-1.21
2023-01-31	-1.23		-1.90	-0.12	-1.21
2022-10-31	-0.86		-7.26	-3.75	-5.47
2022-07-31	-0.76		-4.46	-3.79	-4.07
2022-04-30	-1.84		-3.02	-0.27	-3.16
2022-01-31	-1.84		-3.02	-0.27	-3.16
2021-10-31	-1.13		-1.97	0.48	-1.40
2021-07-31	-1.41		-0.97	0.97	-0.72
2021-04-30	-1.41		-0.97	0.97	-0.72
2021-01-31	-0.85
2020-10-31	-0.43		-1.63	0.52	-1.08
2020-07-31	-0.43		-1.63	0.52	-1.08

Gross Margins

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-04-30
2025-01-31
2024-10-31
2024-07-31	-904.69	-3,300.77	-3,167.08
2024-04-30	-904.69	-3,300.77	-3,167.08
2024-01-31	-635.55	-3,054.85	-2,718.73
2023-10-31	-635.55	-3,054.85	-2,718.73
2023-07-31	-477.85	-2,454.25	-2,212.21
2023-04-30	-0.65	-1,659.35	-1,467.37
2023-01-31	-0.65	-1,659.35	-1,467.37
2022-10-31	-8.17	-1,491.51	-1,387.45
2022-07-31	-1.22	-22.84	-21.28
2022-04-30	-5.78	-358.27	-336.29
2022-01-31	-5.78	-358.27	-336.29
2021-10-31	-4.22	-422.83	-284.60
2021-07-31	1.37	-180.35	-131.40
2021-04-30	1.37	-180.35	-131.40
2021-01-31	-3.04	-278.85	-136.50
2020-10-31	-3.04	-158.55	-151.08
2020-07-31	-3.04	-158.55	-151.08